Entry Point Capital, LLC Liquidia Corp Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 13,078 shares of LQDA stock, worth $211,602. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,078Holding current value
$211,602% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
179Shares Held
47.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$116 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$68.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$57.6 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$53.2 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$51.7 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.04B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...